PRENCIPE, Nunzia
 Distribuzione geografica
Continente #
NA - Nord America 1.620
EU - Europa 856
AS - Asia 518
SA - Sud America 26
AF - Africa 10
OC - Oceania 2
Totale 3.032
Nazione #
US - Stati Uniti d'America 1.589
IT - Italia 402
SG - Singapore 263
CN - Cina 136
IE - Irlanda 106
SE - Svezia 100
DE - Germania 47
AT - Austria 37
FI - Finlandia 34
FR - Francia 29
UA - Ucraina 26
GB - Regno Unito 17
BR - Brasile 16
KR - Corea 16
VN - Vietnam 14
HK - Hong Kong 13
TR - Turchia 13
ID - Indonesia 12
IN - India 12
CA - Canada 11
BE - Belgio 10
CR - Costa Rica 10
MX - Messico 10
PH - Filippine 8
RU - Federazione Russa 8
NL - Olanda 7
JP - Giappone 6
PT - Portogallo 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
GR - Grecia 4
LT - Lituania 4
OM - Oman 4
AR - Argentina 3
CH - Svizzera 3
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
PL - Polonia 3
RO - Romania 3
TH - Thailandia 3
DZ - Algeria 2
EC - Ecuador 2
IL - Israele 2
MA - Marocco 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
KE - Kenya 1
LK - Sri Lanka 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 3.032
Città #
Chandler 303
Singapore 222
Santa Clara 212
Dublin 104
Ashburn 83
Turin 72
Nyköping 63
Torino 57
Houston 48
Columbus 47
Fairfield 47
Beijing 44
Medford 36
Vienna 35
Princeton 30
Milan 28
Ann Arbor 26
Dearborn 24
Wilmington 21
Hangzhou 20
Helsinki 18
Cambridge 17
Fremont 14
Jacksonville 14
Los Angeles 14
Rome 14
Boston 12
Falkenstein 12
Seattle 12
Seoul 12
Woodbridge 12
Hebei 11
Villeurbanne 11
Jakarta 10
Lappeenranta 10
Brussels 9
Dong Ket 9
Hong Kong 9
Redwood City 9
Mexico City 8
Alajuela 7
Istanbul 7
Nuremberg 7
San Mateo 7
Washington 7
Toronto 6
Alessandria 5
Boardman 5
Chengdu 5
London 5
Munich 5
Münster 5
Novara 5
Palermo 5
Piossasco 5
Casorezzo 4
Falls Church 4
Florence 4
Muscat 4
Nanjing 4
New York 4
Ottawa 4
Pisa 4
San Diego 4
Shenyang 4
Silver Spring 4
Abidjan 3
Albignasego 3
Bucharest 3
Colli a Volturno 3
Dubai 3
Genoa 3
Guangzhou 3
Guiyang 3
Kocaeli 3
Norwalk 3
Pune 3
Redmond 3
Royal Leamington Spa 3
Sesto San Giovanni 3
São Paulo 3
Verona 3
Warsaw 3
Amsterdam 2
Bolton 2
Brescia 2
Brno 2
Böblingen 2
Capri 2
Dallas 2
Erba 2
Ercolano 2
Hefei 2
Konya 2
La Tour-de-Peilz 2
Lonigo 2
Messina 2
Miranda 2
Moscow 2
Mumbai 2
Totale 1.974
Nome #
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 260
USEFULNESS OF AN AD HOC QUESTIONNAIRE (ACRO-CQ) FOR THE SYSTEMATIC ASSESSMENT OF ACROMEGALY COMORBIDITIES AT DIAGNOSIS AND THEIR MANAGEMENT AT FOLLOW-UP 199
L'ipopituitarismo post trauma cranico: dall'età pediatrica all'età adulta 123
Increased prevalence of impulse control disorder symptoms in endocrine diseases treated with dopamine agonists: a cross-sectional study 99
First but not second postoperative day growth hormone assessments as early predictive tests for long-term acromegaly persistence 98
The effects of altitude on the hormonal response to physical exercise 91
Neuroendocrine predictors of vasoplegia after cardiopulmonary bypass 89
Retrospective observational analysis of non-irradiated non-functioning pituitary adenomas 83
Comparison of the diagnostic accuracy of 18F-Fluorocholine PET and 11C-Methionine PET for parathyroid localization in primary hyperparathyroidism: A systematic review and meta-analysis 83
Association of Urine Metanephrine Levels with Cardiometabolic Risk: An Observational Retrospective Study 81
Early copeptin determination allows prompt diagnosis of post-neurosurgical central diabetes insipidus 77
Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients 75
Pituitary metastases from neuroendocrine neoplasms: case report and narrative review 72
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatment 70
Development and Internal Validation of a Predictive Model for Adult GH Deficiency Prior to Stimulation Tests 70
Acromegalia e gravidanza: quali rischi per la madre e per il feto 69
Prevalence of primary aldosteronism and association with cardiovascular complications in patients with resistant and refractory hypertension 68
THE CUT-OFF LIMITS OF GH RESPONSE TO INSULIN TOLERANCE TEST RELATED TO BODY MASS INDEX FOR THE DIAGNOSIS OF ADULT GH DEFICIENCY 67
ENDOCRINE DISRUPTING CHEMICALS: EFFECTS ON PITUITARY, THYROID AND ADRENAL GLANDS 66
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view 64
Second-Day Morning Cortisol Levels after Transsphenoidal Surgery Are Accurate Predictors of Secondary Adrenal Insufficiency with Diagnostic Cut-Offs Similar to Those in Non-Stressed Conditions 64
Sindrome della sella vuota 59
Treatment of acromegalic osteopathy in real-life clinical practice: The BAAC (bone active drugs in acromegaly) study 59
Antagonists of growth hormone-releasing hormone inhibit the growth of pituitary adenoma cells by hampering oncogenic pathways and promoting apoptotic signaling 59
Super Giant Growth Hormone−Secreting Pituitary Adenoma in Young Woman: From Ventricles to Nose 58
MORNING SERUM CORTISOL LEVEL PREDICTS CENTRAL ADRENAL INSUFFICIENCY DIAGNOSED BY INSULIN TOLERANCE TEST 58
Diabetic ketoacidosis in acromegaly: a case study—somatostatin analogs adverse event or disease complication? 56
Primary pituitary lymphoma as rare cause of a pituitary mass and hypopituitarism in adulthood 54
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance test 54
The prevalence of silent acromegaly in prolactinomas is very low 49
Are prolactin levels efficient in predicting a pituitary lesion in patients with hyperprolactinemia? 46
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study 46
Adrenocortical, somatotropic, and antidiuretic response to nasal glucagon in healthy subjects. 46
Development and internal validation of a predictive score for the diagnosis of central adrenal insufficiency when morning cortisol is in the grey zone 42
Neuroendocrine response to diclofenac in healthy subjects: a pilot study. 39
Mean GH profile is more accurate than single fasting GH in the evaluation of acromegaly disease control during somatostatin receptor ligands therapy 37
Trabecular Bone Score as an Index of Bone Fragility in Patients with Acromegaly: A Systematic Review and Meta-Analysis. 35
Psychiatric disorders and anger in patients with controlled acromegaly 34
Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives 28
Markers of Aggressiveness in Pituitary Tumors: Update and Perspectives 27
GHRH + arginine test and body mass index: do we need to review diagnostic criteria for GH deficiency? 27
Long-term efficacy of empagliflozin as an add-on treatment for chronic SIAD: a case report and literature review 27
MRI Assessment of Cardiac Function and Morphology in Adult Patients With Growth Hormone Deficiency: A Systematic Review and Meta-Analysis 27
Resistance to Somatostatin Analogs in Italian Acromegaly Patients: The MISS Study 25
Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission 24
Isolated anterior pituitary dysfunction in adulthood 23
Treatment with long-acting somatostatin analogues in patients with acromegaly: when and how 21
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 20
How to position sodium-glucose co-transporter 2 inhibitors in the management of diabetes in acromegaly patients 19
Radiomic Analysis in Pituitary Tumors: Current Knowledge and Future Perspectives 18
Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss. 18
Utility of copeptin in predicting non-pathological postoperative polyuria in patients affected by acromegaly undergoing pituitary neurosurgery. 17
Desmopressin dose requirements in patients with permanent arginine vasopressin deficiency: a tertiary center experience. 13
null 12
Effect of Cabergoline on weight and glucose metabolism in patients with acromegaly. 11
PSYCHIATRIC DISORDERS AND ANGER IN PATIENTS WITH ACROMEGALY DISEASE: A REFERRAL CENTER STUDY 8
Prolactin-secreting tumors, dopamine agonists and pregnancy: a longitudinal experience of a tertiary neuroendocrine center 7
null 1
Totale 3.172
Categoria #
all - tutte 15.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 0 0 26 9 10 5
2020/2021263 10 11 2 9 43 11 21 33 28 30 15 50
2021/2022468 40 15 27 30 33 26 24 17 25 32 108 91
2022/2023796 72 83 12 88 59 166 38 52 98 44 52 32
2023/2024453 48 64 19 28 18 38 33 63 11 43 31 57
2024/2025853 13 92 33 124 356 117 33 67 18 0 0 0
Totale 3.172